The historical development of genetic epilepsy diagnosis

被引：0

作者：

Heyne H.O. ^{[1
]}

Lemke J.R. ^{[1
]}

机构：

[1] Institut für Humangenetik, Universitätsklinikum Leipzig AöR, Philipp-Rosenthal-Str. 55, Leipzig

来源：

Zeitschrift für Epileptologie | 2016年 / 29卷 / 2期

关键词：

Array diagnostics; Genetic testing; Molecular genetics; Next generation sequencing; Panel diagnostics;

D O I：

10.1007/s10309-015-0031-4

中图分类号：

学科分类号：

摘要：

Genetic testing has increasingly gained importance for diagnosing epilepsy disorders. Currently, the underlying genetic cause can be identified in a significant proportion of patients within an appropriate time and at reasonable costs. In numerous cases, it thus provides diagnostic certainty and influences treatment. Knowing the genetic cause of a disorder allows for conclusions on the true phenotypic spectrum, the course and inheritance, and occasionally it influences the choice of therapy. © 2015, Springer-Verlag Berlin Heidelberg.

引用

页码：53 / 56

页数：3

共 17 条

[1]

Rauch A., Hoyer J., Guth S., Et al., Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation, Am J Med Genet A, 140, pp. 2063-2074, (2006)

[2]

Miller D.T., Adam M.P., Aradhya S., Et al., Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies, Am J Hum Genet, 86, pp. 749-764, (2010)

[3]

Kariminejad R., Lind-Thomsen A., Tumer Z., Et al., High frequency of rare copy number variants affecting functionally related genes in patients with structural brain malformations, Hum Mutat, 2011, 32, pp. 1427-1435, (2011)

[4]

Striano P., Coppola A., Paravidino R., Et al., Clinical significance of rare copy number variations in epilepsy: a case-control survey using microarray-based comparative genomic hybridization, Arch Neurol, 69, pp. 322-330, (2012)

[5]

Mefford H.C., Muhle H., Ostertag P., Et al., Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies, PLOS Genet, 6, (2010)

[6]

Mefford H.C., Yendle S.C., Hsu C., Et al., Rare copy number variants are an important cause of epileptic encephalopathies, Ann Neurol, 70, pp. 974-985, (2011)

[7]

de Kovel C.G., Trucks H., Helbig I., Et al., Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies, Brain, 133, pp. 23-32, (2010)

[8]

Garofalo S., Cornacchione M., Di Costanzo A., From genetics to genomics of epilepsy, Neurol Res Int, 2012, (2012)

[9]

Lemke J.R., Riesch E., Scheurenbrand T., Et al., Targeted next generation sequencing as a diagnostic tool in epileptic disorders, Epilepsia, 53, pp. 1387-1398, (2012)

[10]

Dorschner M.O., Amendola L.M., Turner E.H., Et al., Actionable, pathogenic incidental findings in 1,000 participants’ exomes, Am J Hum Genet, 93, pp. 631-640, (2013)

← 1 2 →